Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04069273
Title Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) (SEQUEL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Harry H Yoon
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Paclitaxel + Ramucirumab

Paclitaxel + Pembrolizumab + Ramucirumab

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.